Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension...
Brief Summary
Official Title: “Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%”
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind
Intervention(s) in this Clinical Trial
- Drug: Bimatoprost 0.03%, Travoprost 0.004%
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- · Male or female > 18 years of age
- Naive to treatment or washed off any ocular hypotensive agents
- Untreated IOP >19 mm Hg
- Diagnosis of open-angle glaucoma or ocular hypertension
- Ability to provide informed consent and likely to complete study
Exclusion Criteria:
- · Known contraindication to bimatoprost or travoprost, or any component of any study medication
- Uncontrolled systemic disease
- Active ocular disease other than glaucoma or ocular hypertension
- Required use of ocular medications other than the study medications during the study
- History of intraocular surgery within the last 3 months
- Prior discontinuation of any of the study medications for reasons related to efficacy or safety
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Clinical Trial Investigator Information
Lead Investigator: Innovative Medical Industry
Overall Clinical Trial Officials and Contacts
Robert Noecker, MD Principal Investigator UPMC Eye Center
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00347802
Study ID Number: 5176
ClinicalTrials.gov Identifier: NCT00347802
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00347802
